YM BioSciences, Inc. (YMI) Begins Phase II Trial for Its CYT387 Drug
YM BioSciences Inc. is a drug development company. It is currently advancing three clinical stage products: CYT387, a small molecule,…
YM BioSciences Inc. is a drug development company. It is currently advancing three clinical stage products: CYT387, a small molecule,…
When you’re at home, what kind of electronic entertainment and computer setup do you prefer? The capabilities and arrangement of…
Shares of Elite Pharmaceuticals Inc., a specialty pharmaceutical company, soared in yesterday's trading after the company, along with ECR Pharmaceuticals,…
Commodities king Jim Rogers made the rounds with the media yesterday, speaking to, among others, the The Economic Times of…
Cytori Therapeutics Inc., a developer, manufacturer and seller of medical products and devices to allow the practice of regenerative medicine,…
Located in Seattle, Washington, ecoTECH is a development-stage renewable energy company that produces renewable and sustainable “green” energy products. Today,…
All American Gold Corp. today reported an update on the drilling operations at its Goldfield West Project in Nevada. Drilling,…
MGIC is holding a solid support level at $4.00. There is positive divergence going on with the indicators and the…
China Health Resource Inc. is a producer and supplier of traditional Chinese medicines. The company's current line of products are…
Yesterday, global asset management and social commerce solutions provider Northcore Technologies Inc., made a joint announcement with Discount This Holdings…